Elli Kaplan, Founder & CEO at Neurotrack, joins the podcast to talk about what’s changed over the last two years, the growing cost of inaction, and why a cognitive screener alone may not be enough. Elli shares how Neurotrack is going beyond a score to create a broader cognitive care enablement platform—one designed to bring together the clinical context clinicians need, fit into existing workflows, and support confident decision-making. Elli also look at what it really takes for health systems to implement this kind of solution without adding another disconnected tool to an already complex technology environment. And like we do on so many of our episodes, we’ll look ahead: What could cognitive care look like five years from now if health systems get this right—and what does that mean for patients?
The Millennium Alliance | #millenniumlive | #cognitivehealth
Listen on Spotify, Apple, Amazon Music
About Neurotrack
Neurotrack is a cognitive care enablement platform that helps primary care teams detect, diagnose, and manage cognitive decline earlier. Founded on decades of neuroscience research, Neurotrack replaces outdated paper-based screeners with a fast, reliable digital assessment that fits into routine visits or can be self-administered by patients at home, before an appointment, or anywhere care happens. The result: providers gain the confidence to act on cognitive concerns rather than refer and wait, and patients get answers years sooner.
Earlier detection also carries direct economic value. Under CMS’s V28 risk adjustment model, accurate dementia diagnosis and documentation protect appropriate reimbursement, while earlier intervention reduces the avoidable hospitalizations and emergency utilization that drive costs in undiagnosed populations. With seamless integration into leading EMRs, including Epic, Neurotrack partners with health systems, health plans, and value-based care organizations to close the gap between the first signs of cognitive decline and a documented diagnosis with a care plan behind it.
To learn more, visit www.neurotrack.com
